A carregar...
Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth
Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide. Cetuximab, a human/mouse chimeric monoclonal antibody, is effective in a limited number of CRC patients because of cetuximab resistance. This study aimed to identify novel therapeutic targets in cetuximab-resistant CRC i...
Na minha lista:
| Publicado no: | Biomolecules |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6920916/ https://ncbi.nlm.nih.gov/pubmed/31683810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom9110681 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|